Lipogenic effects of androgen signaling in normal and malignant prostate

por Mah, Chui Yan, Nassar, Zeyad D., Swinnen, Johannes V., Butler, Lisa M.
Publicado 2020

LC3-Associated Phagocytosis (LAP): A Potentially Influential Mediator of Efferocytosis-Related Tumor Progression and Aggressiveness

por Asare, Patrick F., Roscioli, Eugene, Hurtado, Plinio R., Tran, Hai B., Mah, Chui Yan, Hodge, Sandra
Publicado 2020

Endocrine Disruptor Compounds—A Cause of Impaired Immune Tolerance Driving Inflammatory Disorders of Pregnancy?

por Schjenken, John E., Green, Ella S., Overduin, Tenuis S., Mah, Chui Yan, Russell, Darryl L., Robertson, Sarah A.
Publicado 2021

The mTORC1 complex in pre-osteoblasts regulates whole-body energy metabolism independently of osteocalcin

por Tangseefa, Pawanrat, Martin, Sally K., Chin, Peck Yin, Breen, James, Mah, Chui Yan, Baldock, Paul A., Wittert, Gary A., Page, Amanda J., Proud, Christopher G., Fitter, Stephen, Zannettino, Andrew C. W.
Publicado 2021

Targeting hyaluronan-mediated motility receptor (HMMR) enhances response to androgen receptor signalling inhibitors in prostate cancer

por Hinneh, Josephine A., Gillis, Joanna L., Mah, Chui Yan, Irani, Swati, Shrestha, Raj K., Ryan, Natalie K., Atsushi, Enomoto, Nassar, Zeyad D., Lynn, David J., Selth, Luke A., Kato, Masashi, Centenera, Margaret M., Butler, Lisa M.
Publicado 2023

Human DECR1 is an androgen-repressed survival factor that regulates PUFA oxidation to protect prostate tumor cells from ferroptosis

por Nassar, Zeyad D, Mah, Chui Yan, Dehairs, Jonas, Burvenich, Ingrid JG, Irani, Swati, Centenera, Margaret M, Helm, Madison, Shrestha, Raj K, Moldovan, Max, Don, Anthony S, Holst, Jeff, Scott, Andrew M, Horvath, Lisa G, Lynn, David J, Selth, Luke A, Hoy, Andrew J, Swinnen, Johannes V, Butler, Lisa M
Publicado 2020